Psilocybin desynchronizes the human brain
Psilocybin, the active compound in “magic mushrooms,” is being studied for how it disrupts synchronized activity in the brain’s networks, particularly the default mode network linked to self-referential thought. Commenters weigh the promise of this desynchronization for treating depression, PTSD, and entrenched thought patterns against serious risks, especially for people predisposed to psychosis or with underlying mental illness, emphasizing the importance of screening, supervision, and “set and setting.” The thread also reflects broader tensions around psychedelics: fascination with mystical or transformative experiences, skepticism about perceived “profound truths,” concerns over long‑term cognitive effects, and debates on legalization, medicalization, and harm reduction.
Overview of study interpretation
- Discussion centers on psilocybin reducing functional connectivity (FC), especially in the default mode network (DMN), which is associated with inward-focused mentation.
- Some describe this as “desynchronizing” brain regions that usually activate together; others note FC is an abstract, coarse measure with issues such as how to treat negative correlations.
- Commenters stress fMRI’s low temporal resolution and focus on cortex; subcortical and thalamo‑cortical dynamics are likely important but under-resolved.
- There is interest in whether similar desynchronization occurs with LSD and other psychedelics; the paper itself suggests it generalizes at least to LSD.
Cognition, personality, and long-term effects
- Anecdotes: frequent users are described by some as more introspective, less neurotic, and less ego-focused; others strongly disagree or report no such pattern.
- Key open questions: whether reduced FC in DMN implies trade-offs in executive function, intelligence, or job performance; commenters note this remains unclear.
- Some report lasting positive changes (better emotional self‑observation), others report lasting negatives (brain fog, headaches, depersonalization, increased anxiety); mechanisms are unclear.
Subjective experiences and “mystical truths”
- Many describe powerful feelings of awe, insight, and “big sweeping Truths,” but several warn these are feelings, not guaranteed knowledge.
- Psychedelics are said to increase suggestibility and the risk of conspiracy thinking or intense religiosity in some people.
- Comparisons are made to dream states, meditation, and computer/effects‑pedal analogies for brain signaling; some caution against overextending tech metaphors.
Risks, mental health, and safety
- Multiple first-hand stories describe suicides or severe psychological crises following bad trips, often in people later recognized as having latent or familial psychotic vulnerabilities.
- A detailed subthread highlights that psychedelics can precipitate psychotic breaks in predisposed individuals (e.g., schizophrenia risk), especially before midlife.
- Strong advice: people with personal or family history of serious mental illness should be extremely cautious and consult clinicians; even then, risk assessment is imperfect.
- Access to firearms is repeatedly cited as turning transient crises into irreversible deaths; others push back or shift to broader gun‑risk debates.
- Seizure risk is mentioned anecdotally; robust data are noted as lacking.
Set, setting, and therapeutic use
- “Set and setting” are emphasized: mindset, environment, and trusted, sober guides are considered critical for safety and benefit.
- Traditional ceremonial contexts and modern clinical protocols (psilocybin + structured psychotherapy, prep and integration sessions) are contrasted with casual or clandestine use.
- Some advocate supervised trip centers or therapy‑only legalization; others stress personal freedom but agree on the need for better data and education.
Methodological and technical notes
- Sample size in the paper (e.g., n≈7 in key analyses) is criticized as very small; calls are made for n≈1000‑scale studies.
- Dose used (25 mg psilocybin) is described as medium, below typical “heroic” doses; delivery route may alter effective intensity.
- MRI‑during‑trip paradigms are seen as ecologically odd and uncomfortable, potentially biasing results, but still valuable for early mechanistic insight.